Maria Amparo S. O.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS)
- Phase 3 Multicenter Study on Abelacimab vs. Dalteparin for VTE Recurrence and Bleeding in GI/GU Cancer-Associated VTE Patients
- Phase 3 Multicenter Randomized Study of Abelacimab vs. Apixaban on VTE Recurrence and Bleeding in Cancer-Associated Venous Thromboembolism
Data & Insights
Has run more than one trial at 88 of 217 partner sites.
Specializations
Hematological Disorders
The investigator specializes in the treatment of Polycythemia Vera, focusing on innovative therapeutic approaches for managing this blood disorder.
- Blood Volume Management
- Hematocrit Control
- Novel Treatment Modalities
Their expertise extends to subcutaneous therapeutic interventions and phlebotomy requirement optimization.
Thrombosis Management
The investigator focuses on treating venous thromboembolism (VTE), particularly in patients with concurrent cancer diagnoses.
- Cancer-Associated Thrombosis
- Gastrointestinal Cancer Complications
- Genitourinary Cancer Complications
Their research encompasses comparative anticoagulation strategies in oncology patients.
Anticoagulation Management
The investigator specializes in anticoagulation reversal and bleeding risk management in surgical settings.
- Emergency Surgery Protocols
- Bleeding Risk Assessment
- Factor Xa Inhibitor Management
Their work addresses urgent surgical interventions in anticoagulated patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.